FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称BRIVANIB ALANINATE
异名/同义词(1R)-2-((4-((4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY)-5-METHYLPYRROLO(2,1-F)(1,2,4)TRIAZIN-6-YL)OXY)-1-METHYLETHYL (2S)-2-AMINOPROPANOATE
BMS-582664
BMS-582664-02
BRIVANIB ALANINATE
BRIVANIB ALANINATE [INN]
BRIVANIB ALANINATE [JAN]
BRIVANIB ALANINATE [USAN]
BRIVANIB ALANINATE [WHO-DD]
BRIVANIB L-ALANINE ESTER [MI]
L-ALANINE, (1R)-2-((4-((4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY)-5-METHYLPYRROLO(2,1-F)(1,2,4)TRIAZIN-6-YL)OXY)-1-METHYLETHYL ESTER
CAS登记号649735-63-7
物质唯一标识(Unique Ingredient Identifier)U2Y5OFN795
分子式C22H24FN5O4
国际化合物标识(International Chemical Identifier,InChI)LTEJRLHKIYCEOX-OCCSQVGLSA-N
SMILESn1cnc(Oc2ccc3c(c2F)cc([nH]3)C)c4n1cc(c4C)OC[C@H](OC([C@H](C)N)=O)C
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 日本药品名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System